Research reference
Vesugen
A source-linked reference on Vesugen and the KED tripeptide in experimental research. Sources checked 6 September 2026.
Source and review status
Published sources checked
Sources checked on: 6 September 2026
Qualified clinical review: Pending. This page has not been clinically reviewed.
About this source check
AI-assisted editorial source checking covers the cited material and its stated limits. It is not a systematic review, verification of a supplied product, or clinical sign-off.
Editorial role: InfoAddict. Last material change: 6 September 2026. Next source review: 6 December 2026.
Identity
The primary paper identifies KED as Lys-Glu-Asp. Vesugen is the directory label associated with that KED research literature; a product-specific certificate is still needed to confirm that a labelled product contains that sequence.
Sources: PubMed, National Library of Medicine
Research context
The authors examined endothelial expression markers in vitro. A later mouse study also examined KED in an Alzheimer-model context, but neither setting is a human clinical study.
Sources: PubMed, National Library of Medicine
Evidence boundary
These experiments do not demonstrate prevention or treatment of cardiovascular or neurological disease in people. The cited publication is Russian-language with an English abstract.
Sources: PubMed, National Library of Medicine
This source-linked record does not establish a diagnosis, treatment effect, product quality, or personal suitability.
The directory name is therefore linked cautiously to KED research, rather than being treated as proof that all named products have the same molecular identity.
Published sources
- Molecular aspects of vasoprotective peptide KED activity during atherosclerosis and restenosis
PubMed, National Library of Medicine. Published 2016; accessed 6 September 2026.
Supports: The article identifies KED as Lys-Glu-Asp and reports an in-vitro endothelial experiment; reviews associate the research label Vesugen with KED.
Change history
| Date | Change | Clinical-review status |
|---|---|---|
| 6 September 2026 | Source-linked reference published | Pending |
Keep a private record
UpgradeYourself lets you keep private records of routines and observations you choose to discuss with a qualified health professional. This reference does not recommend starting, stopping or changing an item.